C-Bond Systems Is Flying Under The Radar
As we approach the end of the year, our team has become highly focused on identifying businesses that are flying under the radar and are well positioned to capitalize on…
Lexaria Biotechnology Is Nearing An Inflection Point!
A few weeks ago, we highlighted Lexaria Biotechnology (Nasdaq: LEXX) as a biotech firm that is flying under the radar. The company is led by a management team that is…
Safe Supply Streaming: A Deep Dive
Although there is a certain level of immediate attraction to investment opportunities in emerging industries such as the cannabis or psychedelic sectors, we believe that investors must be selective when…
CEO Spotlight: FendX Technologies
This is a paid advertisement on behalf of FendX Technologies Inc. Today, we have FendX Technologies CEO Carolyn Myers with us and we are excited to learn more about her…
FendX Technologies: A Deep Dive
This is a paid message on behalf of FendX Technologies Inc. Although the COVID pandemic created numerous challenges for the global economy, it facilitated the advancement of several industries. From…
Lexaria Biotech: An Undervalued Growth Opportunity
Last month, we highlighted Lexaria Bioscience Corp. (Nasdaq: LEXX) as a biotech company that was trading at a discount and wanted to issue an update after it made several important…
Green Battery Minerals Is An Underappreciated Growth Story
Last month, we published an article of Green Battery Minerals Inc. (TSX-V: GEM) (FSE: BK2P) (WKN: A2QENP) (OTC: GBMIF) as a Canadian junior miner that is flying under the radar…
CEO Spotlight: Green Battery Minerals
Earlier this month, we published an article on Green Battery Minerals Inc. (TSX-V: GEM) (FSE: BK2P) (WKN: A2QENP) (OTC: GBMIF), a Canadian junior miner that is highly focused on mining…
Green Battery Minerals: A Deep Dive
The electric vehicle (EV) revolution represents one of the most attractive current investment themes and we do not expect this to change anytime soon. From an increasing amount of EVs…
Lexaria Bioscience Continues To Execute
Last week, Lexaria Bioscience Corp. (Nasdaq: LEXX) reported two major developments that our readers should be aware of. The more significant announcement was Lexaria awarding a contract for clinical research…
